BioForce Nanosciences (OTCMKTS:BFNH – Get Free Report) announced its earnings results on Monday. The company reported $0.01 EPS for the quarter, Zacks reports.
BioForce Nanosciences Stock Performance
Shares of OTCMKTS BFNH traded down $0.03 during midday trading on Monday, hitting $2.23. 9,450 shares of the company’s stock were exchanged, compared to its average volume of 5,974. BioForce Nanosciences has a 12 month low of $0.18 and a 12 month high of $2.30. The company’s 50 day moving average price is $1.56 and its 200 day moving average price is $0.93.
BioForce Nanosciences Company Profile
BioForce Nanosciences, Inc develops and markets precision instrumentation and proprietary technologies for the production and application of nanoscale materials. Its core platform employs nozzle-driven electrohydrodynamic processes to generate and deposit nanofibers, nanowires and nanoparticles with tight control over diameter, morphology and spatial arrangement. By tailoring electric field parameters and solution properties, the technology enables reproducible fabrication of structures at the nanometer scale.
The company’s product portfolio includes desktop electrospinning systems for nanofiber fabrication, electrospray modules for nanoparticle synthesis and integrated tools for bioprinting and surface patterning.
Featured Stories
- Five stocks we like better than BioForce Nanosciences
- SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
- 3 Dividend Champion Utilities for a Market That Can’t Sit Still
- These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
- First Solar’s Profit Engine Faces a New Policy Test in Washington
Receive News & Ratings for BioForce Nanosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioForce Nanosciences and related companies with MarketBeat.com's FREE daily email newsletter.
